Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.PETVIVO HOLDINGS TO FILE QUARTERLY REPORT ON NOVEMBER 13, 2026; WELCOMES SHAREHOLDER QUESTIONS AND DIALOGUE
PETVIVO ANNOUNCES RELEASE OF TWO REASEARCH ABSTRACTS AND UPCOMING CONFERENCE PRESENTATIONS ON OSTEOARTHRITIS IN RHESUS MACAQUES
Michael Handley Joins PetVivo Holdings, Inc. Board of Directors
Jaime Pickett Joins PetVivo Holdings, Inc. Board of Directors
PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027
PETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATION
PetVivo Holdings, Inc. (PETV) Q1 2027 Earnings Call Transcript
PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027
PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET
PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM
PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM
PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record
PetVivo Holdings, Inc. (PETV) Q4 2026 Earnings Call Prepared Remarks Transcript
PetVivo Reports Financial and Operational Results for Fiscal 2026
PetVivo Reports Financial and Operational Results for Fiscal 2026
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026
PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform
PetVivo Holdings, Inc. (PETV) Discusses Spryng Technology Adoption and Commercial Expansion in Veterinary Practice Transcript
PetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24th